Outlook Therapeutics’s (OTLK) 10-Day exponential moving average is 2.01, while Outlook Therapeutics’s (OTLK) share price is $2.17, making it a Buy.
Outlook Therapeutics’s (OTLK) 100-Day exponential moving average is 1.61, while Outlook Therapeutics’s (OTLK) share price is $2.17, making it a Buy.
Outlook Therapeutics’s (OTLK) stock price is $2.17 and Outlook Therapeutics’s (OTLK) 50-day simple moving average is 1.55, creating a Buy signal.
Outlook Therapeutics’s (OTLK) stock price is $2.17 and Outlook Therapeutics’s (OTLK) 100-day simple moving average is 1.57, creating a Buy signal.
Outlook Therapeutics’s (OTLK) stock price is $2.17 and Outlook Therapeutics’s (OTLK) 200-day simple moving average is 1.60, creating a Buy signal.